Terms: = Head and neck cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Clinical Outcome
2 results:
1. Immunohistochemical detection of "ex novo" HLA-DR in tumor cells determines clinical outcome in laryngeal cancer patients.
Prampolini C; Almadori G; Bonvissuto D; Barba M; Giraldi L; Boccia S; Paludetti G; Galli J; Parolini O; Settimi S; Cadoni G
HLA; 2021 Dec; 98(6):517-524. PubMed ID: 34605215
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of RB1-inducible coiled-coil 1 in salivary gland cancers.
Tameno H; Chano T; Ikebuchi K; Ochi Y; Arai A; Kishimoto M; Shimada T; Hisa Y; Okabe H
Head Neck; 2012 May; 34(5):674-80. PubMed ID: 21717524
[TBL] [Abstract] [Full Text] [Related]
